{
    "id": "74d71770-9595-4cb4-a032-bf7ae0e46972",
    "indications": {
        "text": "tradjenta indicated adjunct diet exercise improve glycemic control adults type 2 diabetes mellitus .",
        "doid_entities": [
            {
                "text": "type 2 diabetes mellitus (DOID:9352)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9352"
            },
            {
                "text": "diabetes (DOID:9351)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9351"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "\u2022 recommended tradjenta 5 mg orally daily ( 2.1 ) \u2022 tradjenta taken without food ( 2.1 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "tradjenta tablets available light red , round , biconvex , bevel-edged , film-coated tablets containing 5 mg linagliptin . tradjenta tablets debossed `` d5 `` one side boehringer ingelheim symbol side . supplied follows : bottles approximately 2640 film-coated tablets , ndc 55154-0410-8 repackaging required , dispense tight container defined usp .",
    "adverseReactions": "tradjenta contraindicated patients hypersensitivity linagliptin excipients tradjenta , anaphylaxis , angioedema , exfoliative skin conditions , urticaria , bronchial hyperreactivity occurred [ ( 5.3 ) ( 6 ) ] .",
    "ingredients": [
        {
            "name": "LINAGLIPTIN",
            "code": "3X29ZEJ4R2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_68610"
        },
        {
            "name": "COPOVIDONE K25-31",
            "code": "D9C330MD8B",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_78913"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_29864"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        }
    ],
    "organization": "Cardinal Health 107, LLC",
    "name": "Tradjenta",
    "effectiveTime": "20250430",
    "indications_original": "TRADJENTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.",
    "contraindications_original": "\u2022 The recommended dosage of TRADJENTA is 5 mg orally once daily ( 2.1 ) \u2022 TRADJENTA can be taken with or without food ( 2.1 )",
    "warningsAndPrecautions_original": "TRADJENTA tablets are available as light red, round, biconvex, bevel-edged, film-coated tablets containing 5 mg of linagliptin. TRADJENTA tablets are debossed with \"D5\" on one side and the Boehringer Ingelheim symbol on the other side.\n                  They are supplied as follows:\n                  Bottles of approximately 2640 film-coated tablets, NDC 55154-0410-8\n                  \n                     If repackaging is required, dispense in a tight container as defined in USP.",
    "adverseReactions_original": "TRADJENTA is contraindicated in patients with hypersensitivity to linagliptin or any of the excipients in TRADJENTA, reactions such as anaphylaxis, angioedema, exfoliative skin conditions, urticaria, or bronchial hyperreactivity have occurred [see Warnings and Precautions (5.3) and Adverse Reactions (6)].",
    "drug": [
        {
            "name": "Tradjenta",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_68610"
        }
    ]
}